SCOPUS 정보 검색 플랫폼

Critical Care Medicine

Volumn 33, Issue 10, 2005, Pages 2428-2431

Drotrecogin alfa (activated) treatment in severe sepsis: A "journal club" review of the global ENHANCE trial

(1) Farmer, J Christopher a

a Mayo Clinic (United States)

Author keywords

Bleeding; Drotrecogin alfa (activated); ENHANCE TRIAL

Indexed keywords

DROTRECOGIN;

CLINICAL TRIAL; DISEASE SEVERITY; DRUG EFFICACY; EDITORIAL; HUMAN; INTENSIVE CARE UNIT; MORTALITY; PRIORITY JOURNAL; RISK REDUCTION; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 26444482163 PISSN: 00903493 EISSN: None Source Type: Journal
DOI: 10.1097/01.CCM.0000182900.73541.24 Document Type: Editorial

Times cited : (8)

References (9)

1
- 26444604781
- Drotrecogin alfa (activated) treatment in severe sepsis for the global open-label trial ENHANCE: Further evidence for survival and safety and implications for early treatment
- Vincent JL, Bernard GR, Beale R, et al: Drotrecogin alfa (activated) treatment in severe sepsis for the global open-label trial ENHANCE: Further evidence for survival and safety and implications for early treatment. Crit Care Med 2005; 33:2266-2277
- (2005) Crit Care Med , vol.33 , pp. 2266-2277
- Vincent, J.L.¹ Bernard, G.R.² Beale, R.³

2
- 0035826096
- Efficacy and safety of recombinant human activated protein C for severe sepsis
- Bernard GR, Vincent JL, Laterre PF, et al: Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001; 344:699-709
- (2001) N Engl J Med , vol.344 , pp. 699-709
- Bernard, G.R.¹ Vincent, J.L.² Laterre, P.F.³

3
- 2942716717
- Extended evaluation of recombinant human activated protein C United States trial (ENHANCE US)
- Bernard GR, Margolis BD, Shanies HM, et al: Extended evaluation of recombinant human activated protein C United States trial (ENHANCE US). Chest 2004; 125:2206-2216
- (2004) Chest , vol.125 , pp. 2206-2216
- Bernard, G.R.¹ Margolis, B.D.² Shanies, H.M.³

4
- 20544462621
- Challenges in using non-randomized studies in systematic reviews of treatment interventions
- Norris SL, Atkins D: Challenges in using non-randomized studies in systematic reviews of treatment interventions. Annals Intern Med 2005; 142:1112-1119
- (2005) Annals Intern Med , vol.142 , pp. 1112-1119
- Norris, S.L.¹ Atkins, D.²

5
- 0036209984
- The design of randomized clinical trials in critically ill patients
- Hébert PC, Cook DJ, Wells G, et al: The design of randomized clinical trials in critically ill patients. Chest 2002; 121:1290-1300
- (2002) Chest , vol.121 , pp. 1290-1300
- Hébert, P.C.¹ Cook, D.J.² Wells, G.³

6
- 0141870148
- Evaluating non-randomised intervention studies
- Deeks JJ, Dinnes J, D'Amico R, et al: Evaluating non-randomised intervention studies. Health Technol Assess 2003; 7:iii-x
- (2003) Health Technol Assess , vol.7
- Deeks, J.J.¹ Dinnes, J.² D'Amico, R.³

7
- 4143148570
- Evidenced-based medicine in the ICU. Important advances and limitations
- Vincent JL: Evidenced-based medicine in the ICU. Important advances and limitations. Chest 2004; 126:592-600
- (2004) Chest , vol.126 , pp. 592-600
- Vincent, J.L.¹

8
- 26444577667
- Guyatt GH, Sackett D, Cook DJ: How to use an article about therapy or prevention. Available at: http://www.cche.net/usersguides/therapy.asp
- How to Use An Article about Therapy or Prevention
- Guyatt, G.H.¹ Sackett, D.² Cook, D.J.³

9
- 0035650856
- Understanding why we agree on the evidence but disagree on the medicine
- Rubenfeld GD: Understanding why we agree on the evidence but disagree on the medicine. Respir Care 2001;45:1442-1449
- (2001) Respir Care , vol.45 , pp. 1442-1449
- Rubenfeld, G.D.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.